68 days ago
With just three patients in phase 1 trials Hemogenyx (HEMO) is at an incredibly early stage of drug development. But at least it is doing something, until recently it has just been a lifestyle business for its cock of a CEO Vlad Sandler. Today a prospectus is out, allowing yet more confetti to start trading. Turn to page 7